Pharmacokinetics of CamSA, a potential prophylactic compound against Clostridioides difficile infections
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 183, 114314
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases
This publication has 50 references indexed in Scilit:
- Burden of Clostridium difficile on the Healthcare SystemClinical Infectious Diseases, 2012
- Spores of Clostridium difficile Clinical Isolates Display a Diverse Germination Response to Bile SaltsPLOS ONE, 2012
- Mouse Relapse Model of Clostridium difficile InfectionInfection and Immunity, 2011
- Mapping Interactions between Germinants and Clostridium difficile SporesJournal of Bacteriology, 2011
- Inhibiting the Initiation ofClostridium difficileSpore Germination using Analogs of Chenodeoxycholic Acid, a Bile AcidJournal of Bacteriology, 2010
- Kinetic Evidence for the Presence of Putative Germination Receptors in C lostridium difficile SporesJournal of Bacteriology, 2010
- Metabolism of Bile Salts in Mice Influences Spore Germination in Clostridium difficilePLOS ONE, 2010
- Bile acids: regulation of synthesisJournal of Lipid Research, 2009
- Chenodeoxycholate Is an Inhibitor of Clostridium difficile Spore GerminationJournal of Bacteriology, 2009
- Bile Salts and Glycine as Cogerminants for Clostridium difficile SporesJournal of Bacteriology, 2008